California State Teachers Retirement System (CalSTRS)
GLUE icon

California State Teachers Retirement System (CalSTRS)’s Monte Rosa Therapeutics GLUE Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Buy
54,196
+50,907
+1,548% +$962K ﹤0.01% 1815
2026
Q1 		$54.1K Buy
3,289
+417
+15% +$7.97K ﹤0.01% 2252
2025
Q4 		$45K Sell
2,872
-179
-6% -$2.41K ﹤0.01% 2306
2025
Q3 		$22.6K Buy
3,051
+2
+0.1% +$11 ﹤0.01% 2515
2025
Q2 		$13.8K Hold
3,049
– – ﹤0.01% 2625
2025
Q1 		$14.1K Hold
3,049
– – ﹤0.01% 2647
2024
Q4 		$21.2K Hold
3,049
– – ﹤0.01% 2588
2024
Q3 		$16.2K Buy
3,049
+841
+38% +$4.25K ﹤0.01% 2696
2024
Q2 		$8.26K Sell
2,208
-903
-29% -$4.6K ﹤0.01% 2956
2024
Q1 		$21.9K Sell
3,111
-1,909
-38% -$11.3K ﹤0.01% 2675
2023
Q4 		$28.4K Sell
5,020
-38,814
-89% -$152K ﹤0.01% 2808
2023
Q3 		$210K Sell
43,834
-3,218
-7% -$20.7K ﹤0.01% 2496
2023
Q2 		$322K Buy
47,052
+19,031
+68% +$123K ﹤0.01% 2462
2023
Q1 		$218K Sell
28,021
-65
-0.2% -$452 ﹤0.01% 2561
2022
Q4 		$214K Buy
28,086
+704
+3% +$5.87K ﹤0.01% 2608
2022
Q3 		$224K Sell
27,382
-453
-2% -$4.16K ﹤0.01% 2610
2022
Q2 		$269K Buy
27,835
+5,424
+24% +$54.5K ﹤0.01% 2593
2022
Q1 		$314K Buy
22,411
+5,808
+35% +$80.6K ﹤0.01% 2549
2021
Q4 		$339K Buy
16,603
+10,351
+166% +$217K ﹤0.01% 2636
2021
Q3 		$139K Buy
+6,252
New +$179K ﹤0.01% 2878

Other funds holding GLUE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

California State Teachers Retirement System (CalSTRS)'s GLUE Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) increased its Monte Rosa Therapeutics (GLUE) stake by 1,548% in Q2 2026, buying an estimated $962K and bringing the position to 54,196 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1815.

California State Teachers Retirement System (CalSTRS) first reported a position in GLUE in Q3 2021 and has held it in 20 quarters since. 192 funds tracked by Wall St. Rank hold GLUE as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 54,196 shares of Monte Rosa Therapeutics worth $1.31M as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) bought 50,907 Monte Rosa Therapeutics shares in Q2 2026, an estimated $962K.
  • Monte Rosa Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #1815 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Monte Rosa Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • 192 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.